MCCASLIN JAMES A
Known title: DirectorCIK: 0001244511
Associated companies
Transaction History
| DCH | ▲ Buy | Grant | 29,773 | $0 | 4/30/2026 | View on chart |
| DCH | ▲ Buy | Grant | 39,474 | $150K | 5/1/2025 | View on chart |
| DCH | ▲ Buy | Grant | 20,492 | $150K | 5/2/2024 | View on chart |
| DCH | ▲ Buy | Grant | 20,030 | $0 | 5/4/2023 | View on chart |
| DCH | ▲ Buy | Grant | 19,095 | $0 | 5/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.